Delivery Order SPE2DB24D1201-SPE2DB25FJEEA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units, with a contract ceiling value of $1,231.28. This firm fixed-price delivery order, which is scheduled for completion by August 19, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed price contract valued at $3,736.67. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate 5 mg chewable tablets (100-count units) valued at $3,794.71 with a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The vendor will perform fulfillment from its Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,852.00 for 100 tablets of Methylphenidate 2.5 mg chewable formulation. This non-set-aside contract was competitively awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order valued at $5,384.48 on July 31, 2025, for the supply of Methylphenidate HCL Chewable Tablets 5mg to the Medical Supply Chain, a Defense-affiliated federal agency. This is a competitively awarded, non-set-aside contract utilizing firm fixed pricing, with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, valued at $4,817.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units, with a contract ceiling value of $3,523.73. The award, which is non-competitive and represents a child contract under a larger vehicle, is scheduled for completion by September 4, 2025. This delivery order operates under a firm fixed price structure and will be performed at the contractor's facility in...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. The contract is valued at $1,541.16 with a firm fixed price structure and an ultimate completion date of August 4, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Methylphenidate 2.5 mg chewable tablets, with a ceiling value of $1,147.90 and a performance period through May 8, 2025. The contract is not set-aside and was awarded on May 7, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $1,191.42. This firm fixed-price delivery order, which represents a child contract, is scheduled for completion by September 12, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation,...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEEADelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units. The contract is valued at $1,516.78 and carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999 through December 2026. The parent contract enables the company to supply a broad spectrum of medications and medical supplies to support military healthcare operations globally. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, regularly fulfills federal medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/12/25 |